Stem Pharm offers synthetic biomaterials for advanced in vitro cellular models and manufacturing and offers the most advanced human neural organoids for disease modeling and drug discovery applications
Location: United States, Wisconsin, Madison
Investors 2
| Date | Name | Website |
| - | Merck Digi... | mds.studio |
| - | First In V... | firstinven... |
Mentions in press and media 1
| Date | Title | Description |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |